Р. Г. Оганов
About
In The Last Decade
Р. Г. Оганов
78 papers receiving 565 citations
Peers
Comparison fields: 5 of 86
- Epidemiology 303
- Cardiology and Cardiovascular Medicine 278
- Pediatrics, Perinatology and Child Health 143
- Surgery 120
- Public Health, Environmental and Occupational Health 101
Countries citing papers authored by Р. Г. Оганов
This map shows the geographic impact of Р. Г. Оганов's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Р. Г. Оганов with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Р. Г. Оганов more than expected).
Fields of papers citing papers by Р. Г. Оганов
This network shows the impact of papers produced by Р. Г. Оганов. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Р. Г. Оганов. The network helps show where Р. Г. Оганов may publish in the future.
Co-authorship network of co-authors of Р. Г. Оганов
This figure shows the co-authorship network connecting the top 25 collaborators of Р. Г. Оганов. A scholar is included among the top collaborators of Р. Г. Оганов based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Р. Г. Оганов. Р. Г. Оганов is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 8 | |
| 3 | 8 | |
| 4 | 3 | |
| 5 | [Drug Treatment of Patients With Ischemic Heart Disease in Russia and Europe: Results of Russian Part of the International Multicenter Study EUROASPIRE IV]. | 2 |
| 6 | 6 | |
| 7 | 2 | |
| 8 | 0 | |
| 9 | SERUM NO LEVELS, CARDIOVASCULAR DISEASE, AND CONCOMITANT INTERNAL PATHOLOGY IN PATIENTS WITH PRIMARY ARTERIAL HYPERTENSION | 1 |
| 10 | Arterial hypertension epidemiology in Russia; the results of 2003-2010 federal monitoring | 21 |
| 11 | Prevalence and specific features of metabolic syndrome in urban adult population | 2 |
| 12 | Conditions necessary for effective prevention of cardiovascular and other non-communicable disease in the Russian Federation | 1 |
| 13 | Assessing the implementation of the recommendations on secondary cardiovascular prevention in patients after myocardial infarction (a pharmaco-epidemiologic study) | 0 |
| 14 | Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 Study | 1 |
| 15 | Stable angina pectoris: population trends, diagnostics, secondary prevention, and antianginal therapy | 1 |
| 16 | Factors influencing cardiovascular mortality in Russian population | 3 |
| 17 | Psychoemotional disorders in cardiovascular patients: problem scope and diagnostics | 2 |
| 18 | Secondary prevention of coronary heart disease in Moscow-population patients with myocardial infarction | 0 |
| 19 | PROLOG Study: decreasing cardiovascular disease risk in hypertensive patients by antihypertensive therapy | 0 |
| 20 | DISORDERS OF PLASMA AND PLATELET PATHWAYS OF HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION COMBINED WITH DISLIPOPROTEINEMIA | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.